VKH
IMUX icon

Virtu KCG Holdings’s Immunic IMUX Stock Holding History

Virtu KCG Holdings’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$86K Buy
74
+29
+64% +$38.7K ﹤0.01% 2457
2017
Q1 		$72K Buy
+45
New +$82.4K ﹤0.01% 2767
2016
Q3 		– Sell
-31
Closed -$78K – 3256
2016
Q2 		$78K Buy
+31
New +$102K ﹤0.01% 2593
2015
Q4 		– Sell
-37
Closed -$59K – 3699
2015
Q3 		$59K Buy
+37
New +$185K ﹤0.01% 2967

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Virtu KCG Holdings's IMUX Position: Q2 2017 in Review

Virtu KCG Holdings increased its Immunic (IMUX) stake by 64% in Q2 2017, buying an estimated $38.7K and bringing the position to 74 shares worth $86K. The position accounts for ﹤0.01% of the portfolio, ranked #2457.

Virtu KCG Holdings first reported a position in IMUX in Q3 2015 and has held it in 4 quarters since. 50 funds tracked by Wall St. Rank hold IMUX as of Q2 2017.

  • Virtu KCG Holdings held 74 shares of Immunic worth $86K as of Q2 2017.
  • Virtu KCG Holdings bought 29 Immunic shares in Q2 2017, an estimated $38.7K.
  • Immunic made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2457 holding.
  • Virtu KCG Holdings first reported a position in Immunic in Q3 2015 and has held it in 4 quarters since.
  • 50 funds tracked by Wall St. Rank held Immunic as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.